HypeCheck

Last verified: 10 days ago

Bacopa Monnieri

Also known as: Brahmi, Water Hyssop, Bacopa, CDRI 08, Bacumen

Evidence under review. — Not yet rated

Ayurvedic herb with modest evidence for attention and stress relief; mixed results on memory.

  • What it does

    Bacopa monnieri is a plant used in traditional Ayurvedic medicine, primarily for brain and cognitive support. Clinical trials using 160–300 mg daily show some improvements in attention, verbal...

  • Evidence quality

    Evidence base hasn't been formally rated yet. See research below.

  • Clinical dose

    160-300 mg daily based on study doses

What the Science Says

Bacopa monnieri is a plant used in traditional Ayurvedic medicine, primarily for brain and cognitive support. Clinical trials using 160–300 mg daily show some improvements in attention, verbal fluency, and stress reduction, though results on overall memory and cognition are inconsistent. Benefits, when observed, tend to emerge after 8–12 weeks of consistent use.

What It Doesn't Do

Won't reliably improve memory — multiple RCTs found no significant difference versus placebo. Not a proven treatment for ADHD or hyperactivity in children. No solid evidence it improves sleep quality. Don't expect overnight results — most studies run 8–12 weeks and still show mixed outcomes.

Evidence-Based Benefits

May reduce self-reported stress and fatigue after mentally demanding tasks in middle-aged adults.

Weak Evidence

Effective at: 300 mg daily

Supporting studies (click to view on PubMed):

May improve attention scores in adults with mild cognitive impairment after 8 weeks.

Weak Evidence

Effective at: 160 mg daily

Supporting studies (click to view on PubMed):

May improve cognitive flexibility and executive function in children aged 6–14 years.

Weak Evidence

Effective at: No established dose from provided studies

Supporting studies (click to view on PubMed):

Absorption & Bioavailability

Unknown — the provided studies do not report pharmacokinetic or absorption data. Bacosides (active compounds) are thought to cross the blood-brain barrier, but bioavailability in humans is not well characterized in these papers.

Red Flags to Watch For

  • Digestive complaints and headaches reported more frequently in Bacopa groups versus placebo in clinical trials
  • Primary cognitive outcomes (verbal learning, working memory, attention) showed no significant improvement in a 12-week RCT of 101 adults
  • Most positive findings are secondary outcomes or subgroup effects — not the main study endpoints
  • Evidence in children is preliminary; only one small trial available and behavioral outcomes were not improved
  • Over 891 registered supplement products exist, suggesting heavy commercialization that may outpace the actual evidence base

Products Containing Bacopa Monnieri

See how Bacopa Monnieri is used in these analyzed products:

Frequently Asked Questions

What does Bacopa Monnieri do?

Ayurvedic herb with modest evidence for attention and stress relief; mixed results on memory.

What is the effective dose of Bacopa Monnieri?

160-300 mg daily based on study doses

Is Bacopa Monnieri safe?

Digestive complaints and headaches reported more frequently in Bacopa groups versus placebo in clinical trials

What doesn't Bacopa Monnieri do?

Won't reliably improve memory — multiple RCTs found no significant difference versus placebo.

Research Sources

  • PubMed
  • NIH DSLD

This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-06-01